The amount of input target protein sample to use depends on the detection limit of the assay, but 10% of the amount added to each binding reaction (3 μl) is usually sufficient. The unbound target ...

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

In a first, scientists have identified promising drug candidates that can permanently disable a key cancer protein once deemed untreatable—a discovery that could revolutionize cancer treatment. Using ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

The global luciferase assay market is set to experience robust growth, with its valuation projected to rise from USD 1,536.70 million in 2024 to USD 3,022.90 million by 2034, registering a CAGR of ...

One important requirement for gel shift assays is that the gel-running conditions not disrupt protein-DNA interactions. These are called nondenaturing conditions, and they differ from the ...

Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

The Zika virus builds tiny tunnels, called tunneling nanotubes, to stealthily transport material needed to infect nearby ...

With the Agilent Certified Pre-Owned refurbishment process, you can be confident that the Certified Pre-Owned AssayMAP Bravo Protein Sample Prep Platform will provide you the same performance as a new ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.